Angiogenesis Inhibitor Bevacizumab Increases the Risk of Ischemic Heart Disease Associated with Chemotherapy: A Meta-Analysis

• Xing-Lin Chen ,

  Contributed equally to this work with: Xing-Lin Chen, Ying-Hong Lei

  Affiliation Key Laboratory of Geriatrics of Health Ministry, Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

  ⨯
• Ying-Hong Lei ,

  Contributed equally to this work with: Xing-Lin Chen, Ying-Hong Lei

  Affiliation Key Laboratory of Geriatrics of Health Ministry, Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

  ⨯
• Cun-Fei Liu,

  Affiliation Department of Geriatrics, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

  ⨯
• Qun-Fang Yang,

  Affiliation Department of Hyperbaric Oxygen Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

  ⨯
• Pei-Yuan Zuo,

  Affiliation Key Laboratory of Geriatrics of Health Ministry, Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

  ⨯
• Cheng-Yun Liu ,

  * E-mail: lcyun@medmail.com.cn

  Affiliation Key Laboratory of Geriatrics of Health Ministry, Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

  ⨯
• Chang-Zhong Chen,

  Affiliation Microarray Core Facility, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America

  ⨯
• Yu-Wei Liu

  Affiliation Key Laboratory of Geriatrics of Health Ministry, Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

  ⨯